Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neal J Meropol

Showing results (151-160 of 226) with videos related to

Pageof 23
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 21, 2008
Induction therapy for poor-prognosis anal canal carcinoma: a phase II study of the cancer and Leukemia Group B (CALGB 9281)Neal J Meropol, Donna Niedzwiecki, Brenda Shank, et al.
Journal of the National Cancer Institute|December 12, 2024
Optimizing public private partnerships to support clinical cancer researchRoy S Herbst, Gideon Blumenthal, Samir N Khleif, et al.
Annals of Surgical Oncology|October 13, 2018
Perceptions of Barriers Towards Active Surveillance for Low-Risk Prostate Cancer: Results From a National Survey of Radiation Oncologists and UrologistsSimon P Kim, Cary P Gross, Nilay D Shah, et al.
Cancer Immunology, Immunotherapy : CII|June 20, 2006
Colon carcinoma cells induce CXCL11-dependent migration of CXCR3-expressing cytotoxic T lymphocytes in organotypic cultureKlara Berencsi, Neal J Meropol, John P Hoffman, et al.
International Journal of Radiation Oncology, Biology, Physics|May 29, 2007
Correlation of molecular response as measured by 18-FDG positron emission tomography with outcome after chemoradiotherapy in patients with esophageal carcinomaAndre A Konski, Jonathan D Cheng, Melvyn Goldberg, et al.
Journal of Oncology Practice|March 19, 2019
Implementing an Electronic End-of-Life Chemotherapy Utilization MeasureJoshua Kraut, Kathi Mooney, John W Sweetenham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 30, 2012
Association between VEGF splice isoforms and progression-free survival in metastatic colorectal cancer patients treated with bevacizumabDavid O Bates, Paul J Catalano, Kirsty E Symonds, et al.
Urologic Oncology|August 8, 2017
Association of race and margin status among patients undergoing robotic partial nephrectomy for T1 renal cell carcinoma: Results from a population-based cohortVictor S Chen, Robert Abouassaly, Christopher M Gonzalez, et al.
American Journal of Clinical Oncology|May 12, 2010
Phase II and coagulation cascade biomarker study of bevacizumab with or without docetaxel in patients with previously treated metastatic pancreatic adenocarcinomaIgor A Astsaturov, Neal J Meropol, R Katherine Alpaugh, et al.
NEJM Evidence|May 21, 2024
Broadening Eligibility Criteria and Diversity among Patients for Cancer Clinical TrialsManeet Kaur, Filip Frahm, Yichen Lu, et al.
Pageof 23

Showing results (151-160 of 226) with videos related to

Sort By:
Pageof 23
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 21, 2008
Induction therapy for poor-prognosis anal canal carcinoma: a phase II study of the cancer and Leukemia Group B (CALGB 9281)Neal J Meropol, Donna Niedzwiecki, Brenda Shank, et al.
Journal of the National Cancer Institute|December 12, 2024
Optimizing public private partnerships to support clinical cancer researchRoy S Herbst, Gideon Blumenthal, Samir N Khleif, et al.
Annals of Surgical Oncology|October 13, 2018
Perceptions of Barriers Towards Active Surveillance for Low-Risk Prostate Cancer: Results From a National Survey of Radiation Oncologists and UrologistsSimon P Kim, Cary P Gross, Nilay D Shah, et al.
Cancer Immunology, Immunotherapy : CII|June 20, 2006
Colon carcinoma cells induce CXCL11-dependent migration of CXCR3-expressing cytotoxic T lymphocytes in organotypic cultureKlara Berencsi, Neal J Meropol, John P Hoffman, et al.
International Journal of Radiation Oncology, Biology, Physics|May 29, 2007
Correlation of molecular response as measured by 18-FDG positron emission tomography with outcome after chemoradiotherapy in patients with esophageal carcinomaAndre A Konski, Jonathan D Cheng, Melvyn Goldberg, et al.
Journal of Oncology Practice|March 19, 2019
Implementing an Electronic End-of-Life Chemotherapy Utilization MeasureJoshua Kraut, Kathi Mooney, John W Sweetenham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 30, 2012
Association between VEGF splice isoforms and progression-free survival in metastatic colorectal cancer patients treated with bevacizumabDavid O Bates, Paul J Catalano, Kirsty E Symonds, et al.
Urologic Oncology|August 8, 2017
Association of race and margin status among patients undergoing robotic partial nephrectomy for T1 renal cell carcinoma: Results from a population-based cohortVictor S Chen, Robert Abouassaly, Christopher M Gonzalez, et al.
American Journal of Clinical Oncology|May 12, 2010
Phase II and coagulation cascade biomarker study of bevacizumab with or without docetaxel in patients with previously treated metastatic pancreatic adenocarcinomaIgor A Astsaturov, Neal J Meropol, R Katherine Alpaugh, et al.
NEJM Evidence|May 21, 2024
Broadening Eligibility Criteria and Diversity among Patients for Cancer Clinical TrialsManeet Kaur, Filip Frahm, Yichen Lu, et al.
Pageof 23